Wordt geladen...
Esketamine for treatment resistant depression: a trick of smoke and mirrors?
In March 2019, the US Food and Drug Administration (FDA) approved a nasal spray formulation of esketamine for the treatment of resistant depression in adults. Esketamine is the S-enantiomer of ketamine, an FDA-approved anaesthetic, known to cause dissociation and, occasionally, hallucinations. While...
Bewaard in:
| Gepubliceerd in: | Epidemiol Psychiatr Sci |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Cambridge University Press
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8061126/ https://ncbi.nlm.nih.gov/pubmed/31841104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S2045796019000751 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|